Vés al contingut

Escherichia coli productora de shigatoxines

De la Viquipèdia, l'enciclopèdia lliure
(S'ha redirigit des de: Shiga Toxine Escherichia Coli)

L'Escherichia coli productora de shigatoxines (en anglès:Shiga Toxine Escherichia Coli, STEC) és un bacteri productor de potents toxines[1] i responsable d'algunes intoxicacions alimentàries[2][3] causants de colitis hemorràgiques[4] i -en casos greus- de la síndrome hemolítica i urèmica,[5][6] la principal causa d'insuficiència renal aguda en nens petits.[7] Es coneixen múltiples soques del bacteri, no totes elles amb la mateixa virulència.[8][9] El seu reservori principal són els remugants,[10] encara que s'han registrat diversos casos d'infeccions humanes associades al contacte amb ocells, gossos o cavalls.[11]

Aquest microorganisme es coneix també sota altres noms, com enterohemorrhagic E. coli (EHEC),[12] Shiga-like toxin-producing E. coli (SLTEC o STEC),[13] hemolytic uremic syndrome–associated enterohemorrhagic E. coli (HUSEC) i verocytotoxin o verotoxin-producing E. coli (VTEC).[14]

Shiga fa referència a Kiyoshi Shiga[15] qui descobrí Shigella dysenteriae[16] una de les espècies que formen el gènere Shigella.[17]

Referències

[modifica]
  1. ↑ Melton-Celsa, AR «Shiga Toxin (Stx) Classification, Structure, and Function» (en anglès). Microbiol Spectr, 2014; 2 (2), pàgs: 24. PMID: 25530917. DOI: 10.1128/microbiolspec.EHEC-0024-2013. PMC: 4270005 [Consulta: 25 maig 2020].
  2. ↑ Vernozy-Rozand, C; Montet, MP; Berardin, M; Bavai, C; Beutin, L «Isolation and characterization of Shiga toxin-producing Escherichia coli strains from raw milk cheeses in France» (en anglès). Lett Appl Microbiol, 2005; 41 (3), pp: 235-241. ISSN 1472-765X. DOI: 10.1111/j.1472-765X.2005.01756.x. PMID: 16108913 [Consulta: 25 maig 2020].
  3. ↑ Rípodas Navarro, A; Fernández Moreira, D; Macho Martínez, M «Investigación de Escherichia Coli productor de toxinas Shiga (STEC) en carnes y derivados cárnicos» (en castellà). Sanid Mil, 2017 Jul-Set;, pp: 147-152. ISSN 1887-8571. DOI: 10.4321/s1887-85712017000300002 [Consulta: 25 maig 2020].
  4. ↑ Fiorito, P; Burgos, JM; Miyakawa, MF; Rivas, M; et al «Effect of Shiga toxin 2 on water and ion transport in human colon in vitro» (en anglès). Dig Dis Sci, 2000 Mar; 45 (3), pp: 480-486. ISSN 0163-2116. DOI: 10.1023/a:1005480720832. PMID: 10749321 [Consulta: 3 juny 2020].
  5. ↑ Decludt, B; Bouvet, P; Mariani-Kurkdjian, P; Grimont, F; Grimont, PA; Hubert, B; et al «Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France» (en anglès). Epidemiol Infect, 2000 Abr; 124 (2), pp: 215-220. PMID: 10813145. DOI: 10.1017/s0950268899003623. PMC: 2810903 [Consulta: 25 maig 2020].
  6. ↑ Espié, E; Grimont, F; Mariani-Kurkdjian, P; Bouvet, P; Haeghebaert, S; Filliol, I; et al «Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006» (en anglès). Pediatr Infect Dis J, 2008 Jul; 27 (7), pp: 595-601. ISSN 0891-3668. DOI: 10.1097/INF.0b013e31816a062f. PMID: 18520972 [Consulta: 25 maig 2020].
  7. ↑ Gerber, A; Karch, H; Allerberger, F; Verweyen, HM; Zimmerhackl, LB «Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study» (en anglès). J Infect Dis, 2002 Ag 15; 186 (4), pp: 493-500. ISSN 1537-6613. DOI: 10.1086/341940. PMID: 12195376 [Consulta: 3 juny 2020].
  8. ↑ Boerlin, P; McEwen, SA; Boerlin-Petzold, F; Wilson, JB; et al «Associations Between Virulence Factors of Shiga Toxin-Producing Escherichia Coli and Disease in Humans» (en anglès). J Clin Microbiol, 1999 Mar; 37 (3), pp: 497-503. PMID: 9986802. DOI: 10.1128/JCM.37.3.497-503.1999. PMC: 84443 [Consulta: 26 maig 2020].
  9. ↑ Bertin, Y; Boukhors, K; Pradel, N; Livrelli, V; Martin, C «Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors» (en anglès). J Clin Microbiol, 2001 Set; 39 (9), pp: 3060-3065. PMID: 11526129. DOI: 10.1128/JCM.39.9.3060-3065.2001. PMC: 88297 [Consulta: 26 maig 2020].
  10. ↑ ACSA «E. coli productor de toxina Shiga (ECTS o STEC)». Departament de Salut, Generalitat de Catalunya, 2019; Set 2 (rev), pàgs: 3 [Consulta: 25 maig 2020].
  11. ↑ Larson, DG «Prevalence of shiga toxin-producing Escherichia coli in the Sacramento valley equine population -Tesi doctoral-» (en anglès). California State University, Sacramento, 2009; tardor, pàgs: 57 [Consulta: 26 maig 2020].
  12. ↑ Institut Pasteur «Enterohemorrhagic E. coli (EHEC)» (en anglès). Disease sheets, 2019; Set 16 (rev), pàgs: 8 [Consulta: 24 maig 2020].
  13. ↑ Beutin, L; Steinrück, H; Krause, G; Steege, K; et al «Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shigatoxin producing strains of Escherichia coli (STEC) from food and other sources» (en anglès). J Appl Microbiol, 2007 Mar; 102 (3), pp: 630-639. ISSN 1365-2672. DOI: 10.1111/j.1365-2672.2006.03139.x. PMID: 17309611 [Consulta: 25 maig 2020].
  14. ↑ Karch, H; Tarr, P; Bielaszewska, M «Enterohaemorrhagic Escherichia coli in human medicine» (en anglès). Int J Med Microbiol, 295, 6-7, 05-10-2005, pp: 405–418. ISSN 1438-4221. DOI: 10.1016/j.ijmm.2005.06.009. PMID: 16238016.
  15. ↑ Fresquet, JL «Kiyoshi Shiga (1871-1957)» (en castellà). Historiadelamedicina.org, 2002; Set, págs: 6 [Consulta: 25 maig 2020].
  16. ↑ ITIS «Shigella dysenteriae (Shiga, 1898) Castellani and Chalmers, 1919» (en anglès). Standard Report Page, 2020 Gen 17; 966038 (rev), pàgs: 2 [Consulta: 26 maig 2020].
  17. ↑ Strockbine, NA; Jackson, MP; Sung, LM; Holmes, RK; O'Brien, AD «Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1» (en anglès). J Bacteriol, 1988; Mar; 170(3), pp: 1116-1122. PMID: 2830229. DOI: 10.1128/jb.170.3.1116-1122.1988. PMC: 210880 [Consulta: 25 maig 2020].

Bibliografia

[modifica]
Aquest article té bibliografia, però no se sap quina referència verifica cada part.
Podeu millorar aquest article assignant cadascuna d'aquestes obres a frases o paràgrafs concrets.
  • O'Brien, S. J.; Adak, G. K.; Gilham, C. Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans (en anglès). Emerg Infect Dis, 2001 Nov-Des; 7 (6), pp: 1049-1051. PMID: 11747741. DOI 10.3201/eid0706.010626 [Consulta: 25 maig 2020]. 
  • Groupe de travail «STEC». Bilan des connaissances relatives aux Escherichia coli producteurs de Shiga-toxines (STEC) (en francès). AFSSA, 2003; Abr, págs: 220 [Consulta: 25 maig 2020]. 
  • Douellou, Thomas. Pathogénicité des Escherichia coli producteurs de Shiga-toxines (STEC) des produits laitiers: diversité génétique et impact des globules gras du lait -Tesi doctoral- (en francès). Sciences agricoles. Université Blaise Pascal - Clermont-Ferrand, 2017; Feb NNT: 2016CLF22712, págs: 296 [Consulta: 25 maig 2020]. 
  • Barua, S., Yamashino, T., Hasegawa, T., Yokoyama, K., Torii, K. and Ohta, M. (2002) Involvement of surface polysaccharides in the organic acid resistance of Shiga Toxin-producing Escherichia coli O157:H7. Mol Microbiol. 43: 629-640.
  • Beutin, L., Zimmermann, S. and Gleier, K. (1996) Rapid detection and isolation of shiga-like toxin (verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay. J Clin Microbiol. 34: 2812-2814
  • Brett, K.N., Hornitzky, M.A., Bettelheim, K.A., Walker, M.J. and Djordjevic, S.P. (2003) Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx2-EDL933 and/or stx2vhb subtypes. J Clin Microbiol. 41: 2716-2722.
  • Cebula, T.A., Payne, W.L. and Feng, P. (1995) Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assaymultiplex PCR. J Clin Microbiol. 33: 248-250.
  • Cookson, A.L., Cooley, W.A. and Woodward, M.J. (2002) The role of type 1 and curli fimbriae of Shiga toxin-producing Escherichia coli in adherence to abiotic surfaces. Int J Med Microbiol. 292: 195-205
  • Erwert, R.D., Eiting, K.T., Tupper, J.C., Winn, R.K., Harlan, J.M. and Bannerman, D.D. (2003) Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis. Microb Pathog. 35: 87-93.
  • Fach, P., Perelle, S., Dilasser, F. and Grout, J. (2001) Comparison between a PCR-ELISA test and the vero cell assay for detecting Shiga toxin-producing Escherichia coli in dairy products and characterization of virulence traits of the isolated strains. J Appl Microbiol. 90: 809-818.
  • Fernandez, G.C., Lopez, M.F., Gomez, S.A., Ramos, M.V., Bentancor, L.V., Fernandez-Brando, R.J., et al (2006) Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol. 146: 76-84.
  • Foster, G.H., Armstrong, C.S., Sakiri, R. and Tesh, V.L. (2000) Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases. Infect Immun. 68: 5183-5189
  • Gannon, V.P., Teerling, C., Masri, S.A. and Gyles, C.L. (1990) Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. J Gen Microbiol. 136: 1125-1135.
  • Gourmelon, M., Montet, M.P., Lozach, S., Le Mennec, C., Pommepuy, M., Beutin, L. and Vernozy- Rozand, C. (2006) First isolation of Shiga toxin 1d producing Escherichia coli variant strains in shellfish from coastal areas in France. J. Appl. Microbiol. 100: 85-97.
  • Greatorex, J.S. and Thorne, G.M. (1994) Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharidein hemolytic-uremic syndrome patients and healthy subjects. Journal of Clinical Microbiology. 32: 1172-1178.
  • Hurley, B.P., Jacewicz, M., Thorpe, C.M., Lincicome, L.L., King, A.J., Keusch, G.T. and Acheson, D.W. (1999) Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun. 67: 6670-6677.
  • Jenkins, C., Perry, N.T., Cheasty, T., Shaw, D.J., Frankel, G., Dougan, G., et al (2003) Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origins. J Clin Microbiol. 41: 1775-1778.
  • Klie, H., Timm, M., Richter, H., Gallien, P., Perlberg, K.W. and Steinruck, H. (1997) Detection and occurrence of verotoxin-forming and/or shigatoxin producing Escherichia coli (VTEC and/or STEC) in milk.. Berl Munch Tierarztl Wochenschr. 110: 337-341.
  • Lea, N., Lord, J.M. and Roberts, L.M. (1999) Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli O157:H7 Shiga-like toxin-1. Microbiology. 145 (Pt 5): 999-1004.
  • Louise, C.B. and Obrig, T.G. (1995) Specific interaction of Escherichia coli O157:H7 derived Shigalike toxin II with human renal endotheial cells. Journal of Infections diseases. 172: 1397-1401
  • Ludwig, K., Petric, M., Blanchette, V. and Karmali, M. (1998) Isolated thrombocytopenic purpura associated with infection due to verocytotoxin (Shiga toxin)-producing Escherichia coli serotype O26:H11. Clin Infect Dis. 27: 660-661.
  • Paton, A.W., Srimanote, P., Woodrow, M.C. and Paton, J.C. (2001) Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun. 69: 6999-7009.
  • Schuller, S., Frankel, G. and Phillips, A.D. (2004) Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell Microbiol. 6: 289-301.
  • Thorpe, C.M., Smith, W.E., Hurley, B.P. and Acheson, D.W. (2001) Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun. 69: 6140-6147.
  • Vernozy-Rozand, C., Montet, M.P., Bertin, Y., Trably, F., Girardeau, J.P., Martin, C., et al (2004) Serotyping, stx2 subtyping, and characterization of the locus of enterocyte effacement island of shiga toxin-producing Escherichia coli and E. coli O157:H7 strains isolated from the environment in France. Appl Environ Microbiol. 70: 2556-2559.

Enllaços externs

[modifica]
Obtingut de «https://ca.wikipedia.org/w/index.php?title=Escherichia_coli_productora_de_shigatoxines&oldid=33205966»